A cross-linked hyaluronic acid filler with 0.3% lidocaine for enhanced comfort. Designed for injection into the mid to deep dermis to correct light to moderate nasolabial folds.
Key Benefits
High HA concentration (23 mg/mL) with advanced crosslinking
Proven results up to 9 months post-treatment
Includes 2 x 27G ½” Terumo™ needles
Indications (Canada)
saypha® filler Lidocaine is indicated for intradermal injection into the mid todeep dermisfor correction of light to moderate nasolabial folds.
Product Specifications
HA Concentration
23 mg/mL
Lidocaine
0.3%
Crosslinking Agent
BDDE (≤2 ppm)
Injection Depth
Mid to deep dermis
Syringe Volume
1.0 mL
Sterilization
Steam sterilized
Clinical Highlights
93% satisfaction rate at 9 months
Low extrusion force and optimal viscosity for practitioner control
*This product is intended for use by licensed healthcare professionals only. Always refer to the official IFU prior to use.
